ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
COMPASS Pathways PLC

COMPASS Pathways PLC (CMPS)

4.125
0.185
( 4.70% )
Updated: 03:32:45

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
4.125
Bid
4.12
Offer
4.13
Volume
451,229
3.9082 Day's Range 4.1798
0.00 52 Week Range 0.00
Market Cap
Previous Close
3.94
Open
3.93
Last Trade
1212
@
4.125
Last Trade Time
03:33:51
Financial Volume
US$ 1,833,804
VWAP
4.064
Average Volume (3m)
-
Shares Outstanding
68,390,000
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
4.88M
Net Profit
-118.46M

About COMPASS Pathways PLC

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing ther... Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. Show more

Sector
Offices-holdng Companies,nec
Industry
Offices-holdng Companies,nec
Headquarters
Cheshire, Gbr
Founded
-
COMPASS Pathways PLC is listed in the Offices-holdng Companies sector of the NASDAQ with ticker CMPS. The last closing price for COMPASS Pathways was US$3.94. Over the last year, COMPASS Pathways shares have traded in a share price range of US$ 0.00 to US$ 0.00.

COMPASS Pathways currently has 68,390,000 shares in issue. The market capitalisation of COMPASS Pathways is US$269.46 million.

CMPS Latest News

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Newly created role of Chief Patient Officer reinforces Compass’ vision of working to achieve broad and equitable access to COMP360, if approved Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a...

Compass Pathways Announces Pricing of Underwritten Offering

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten...

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today its common stock will be added...

Compass Pathways to Participate in December Investor Conferences

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of the executive...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

CMPS - Frequently Asked Questions (FAQ)

What is the current COMPASS Pathways share price?
The current share price of COMPASS Pathways is US$ 4.125
How many COMPASS Pathways shares are in issue?
COMPASS Pathways has 68,390,000 shares in issue
What is the market cap of COMPASS Pathways?
The market capitalisation of COMPASS Pathways is USD 269.46M
What is the 1 year trading range for COMPASS Pathways share price?
COMPASS Pathways has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the reporting currency for COMPASS Pathways?
COMPASS Pathways reports financial results in USD
What is the latest annual turnover for COMPASS Pathways?
The latest annual turnover of COMPASS Pathways is USD 4.88M
What is the latest annual profit for COMPASS Pathways?
The latest annual profit of COMPASS Pathways is USD -118.46M
What is the registered address of COMPASS Pathways?
The registered address for COMPASS Pathways is 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE, WA14 2DT
What is the COMPASS Pathways website address?
The website address for COMPASS Pathways is www.compasspathways.com
Which industry sector does COMPASS Pathways operate in?
COMPASS Pathways operates in the OFFICES-HOLDNG COMPANIES,NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KRKR36Kr Holdings Inc
US$ 9.8401
(131.54%)
6.39M
SLXNSilexion Therapeutics Corporation
US$ 2.3899
(77.03%)
189.38M
BNZIBanzai International Inc
US$ 1.8301
(46.41%)
16.55M
SXTP60 Degrees Pharmaceuticals Inc
US$ 1.01
(31.03%)
50.02M
REBNReborn Coffee Inc
US$ 2.2232
(30.78%)
255.4k
ZKINZK International Group Co Ltd
US$ 0.5306
(-35.19%)
2.11M
BACKIMAC Holdings Inc
US$ 0.7961
(-34.75%)
1.48M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0384
(-33.56%)
59.27M
MGOLMGO Global Inc
US$ 0.1129
(-32.11%)
30.4M
EYENEyenovia Inc
US$ 0.0391
(-31.40%)
11.42M
SLXNSilexion Therapeutics Corporation
US$ 2.3801
(76.30%)
189.38M
NVDANVIDIA Corporation
US$ 123.16
(-4.52%)
156.81M
OCEAOcean Biomedical Inc
US$ 0.3633
(10.09%)
152.88M
RIMEAlgorhythm Holdings Inc
US$ 0.0265
(-14.24%)
74.66M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.50
(8.67%)
67.47M

CMPS Discussion

View Posts
ListenToMe ListenToMe 1 month ago
The Psycedelic Bull run is about to begin. I agree 100 % 💯

Also keep an eye on tge psychedelic etf PSIL if you're looking for exposure to the sector but not sure which company to buy.
👍️0
LORTAP KCOTS LORTAP KCOTS 1 month ago
The whole group should be going up soon.
👍️ 1
ListenToMe ListenToMe 1 month ago
The time is near folks. $3.95 currently.

Cmps is about to start going g Up.
👍️0
MomsSpaghetti MomsSpaghetti 3 months ago
ooof! Glad I didn't have this one. ATAI recently got rid of most of their share of CMPS which was good after this news.

MNMD and ATAI for the win in this sector.
👍️0
dinogreeves dinogreeves 5 months ago
Awesome mid to long term hold. Could see 30-40 dollars by end of the year.
👍️0
Monksdream Monksdream 11 months ago
CMPS new 52 week high
👍️0
Monksdream Monksdream 1 year ago
CMPS new 52=week high
👍️0
Copilotdog Copilotdog 1 year ago
There will be no mushroom boom. The Fed’s will crush it. Shorting this to $3
👍️0
Monksdream Monksdream 1 year ago
This podcast is an absolute screaming hilarious analysis of psycho stocks
👍️0
Monksdream Monksdream 1 year ago
Uh, you know, we live now in technology driven world
In times past ever since the Industrial Revolution wealth was created primarily from natural resources
But that isn’t exactly the etched in stone fact
Prior to the mid-1850s there was the Scientific Revolution that began in the 1400s
The academic discipline of chemistry in some unforeseen way led to the accidental discovery by a Swiss chemist who walked to his lab well into his 80s
That said, as far as US stock market sectors are concerned, the medical sector is by far the largest in terms of the number of companies in which a retail or professional asset manager deploying other people’s money can invest
Close to 1 000 public traded companies
It is in my view pretty much a crap shoot when it comes finding one that is equivalent to Microsoft
With that said one should, in the long run, expect disappointment to be the norm rather than the exception
👍️0
LORTAP KCOTS LORTAP KCOTS 1 year ago
Last time I owned this, was when I sold it over $70, really dodged a bullet on this one.. unfortunately I own MNMD.. and it’s just as bad of a fall down shit show
👍️0
Monksdream Monksdream 1 year ago
CMPS new 52 week low
👍️0
Monksdream Monksdream 2 years ago
CMPS over $10

https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
👍️0
Monksdream Monksdream 2 years ago
CMPS nearing resistance break it and it goes higher
👍️0
Denisnj Denisnj 2 years ago
Definitely overpriced. Government needs slaves. No way they'll let humanity awaken
👍️0
starman2 starman2 2 years ago
https://investorplace.com/2022/07/dear-psychedelic-stocks-fans-watch-this-key-catalyst/
👍️0
starman2 starman2 2 years ago
https://www.benzinga.com/analyst-ratings/analyst-color/22/08/28522479/these-depression-players-are-hc-wainwrights-top-picks-for-400b-mental-healthcare-ma

(shared via bit.ly/mystocksapp)
👍️0
starman2 starman2 2 years ago
On fire.. So glad i jumped in.
👍️0
ListenToMe ListenToMe 3 years ago
Are you peeps watching PSYCF? I definitely think it's going to become the LEADER and Catalyst for the Mushroom sector!
👍️0
ListenToMe ListenToMe 3 years ago
Best mushroom play is PSYCF!!! Pay Attn.


.PSYCF





.
👍️0
ListenToMe ListenToMe 3 years ago
Awesome mushroom video & sound https://mobile.twitter.com/PsychedWellness/status/1478556314309648389
👍️0
BesaoT35 BesaoT35 3 years ago
Psychedelics are very safe drugs. A long term remission in treatment resistant major depression is a highly valuable and rare benefit to achieve for these patients.

On occasion there are reported cases of a psychosis induced, usually when that happens it is on very large doses of psychedelics perhaps combined with a non supportive environment.

Psilocybin causes fewer of these outcomes I have heard and is perhaps a less intense experience. Psilocybin is known to be a shorter acting psychedelic than LSD is.

Sedatives such as Valium or Xanax should be available if needed or desired at the end of the session in my opinion. Otherwise the process of coming down from the peak experience can be a drawn out and somewhat unpleasant process.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
I love this stock!! Just flipped this for a $1500 profit in 24 hrs..
👍️0
BesaoT35 BesaoT35 3 years ago
The clinical study for Treatment Resistant Major Depression looked very successful. Can a psychiatrist prescribe this patented psilocybin similar to how cannabis is illegal but medical doctors recommend it’s use legally for medical dispensaries?

How are they able to patent a known plant chemical? They claim to have a patented form of psilocybin.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Thank god I sold this.
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
This stock has really come back nicely!!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Awesome, just made $7700 on this trade!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Crushing upward today!!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Nice volume and nice price movement
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
This thing is moving up!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Big news today!!!
👍️0
LORTAP KCOTS LORTAP KCOTS 3 years ago
Steady increases, looks like we can get past $40 and then maybe $50?
👍️0
LORTAP KCOTS LORTAP KCOTS 4 years ago
WTF???
👍️0
Glider549 Glider549 4 years ago
Sure was.
Schroom pharma is really advancing.
👍️0
LORTAP KCOTS LORTAP KCOTS 4 years ago
Nice movement today
👍️0
Tower of Hanoi Tower of Hanoi 4 years ago
Nice interview. Now that ketamine therapy is in use, I really don't see any significant roadblocks to further expansion into other drugs.

Execution will be critical, plus how many competitors end up in the space.
👍️0
Investopotia Investopotia 4 years ago
New CEO Interview
👍️0
Tower of Hanoi Tower of Hanoi 4 years ago
I can't think of a better speculative space right now!

GLTA!
👍️0
Tower of Hanoi Tower of Hanoi 4 years ago
Tiny, tiny position today:

10 shares @35.

Nice spec.


MY OPINION ONLY.
👍️0
0001-stocks 0001-stocks 4 years ago
NEW BOARD!!! Psychedelic Stocks (link here)

https://investorshub.advfn.com/Psychedelic-Stocks-39490/
👍️0
ReviveThomas ReviveThomas 4 years ago
I've eyeballed CMPS but not new to shroom stocks. What's the deal with this. Clinicaltrials.gov trial for treatment resistant depression in may ? Is that right?
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Up 4.05
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Going up
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Could this we thousands dollar stock lollllll
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Wowwwwwww
👍️0
WebSlinger WebSlinger 4 years ago
***PR OUT***

COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences

London, UK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management team will participate in two investor conferences during the week of 11 January 2021.

George Goldsmith, Chairman, CEO and Co-founder, and Lars Wilde, President, Chief Business Officer, and Co-founder, will be participating in a fireside chat available on demand from 11 to 14 January in conjunction with the HC Wainwright BioConnect 2021 Conference.

George Goldsmith and Lars Wilde will also present a business update and hold a fireside chat at 12:15 pm ET on 14 January at the Westwicke Healthcare Day at the ICR Conference 2021.

Audio webcasts of the fireside chats will be available on the "Events" page of the Investors section of the COMPASS website at https://ir.compasspathways.com/news-events/events. A replay of events will be available for 30 days following the event.

https://www.globenewswire.com/news-release/2021/01/06/2154099/0/en/COMPASS-Pathways-plc-to-participate-in-HC-Wainwright-and-ICR-investor-conferences.html
👍️0
excboe excboe 4 years ago
CMPS ARTICLE. Sketchy https://www.google.com/amp/s/qz.com/1454785/a-millionaire-couple-is-threatening-to-create-a-magic-mushroom-monopoly/amp/
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 4 years ago
Wowwwwww so much cash
👍️0
WebSlinger WebSlinger 4 years ago
CMPS has $196.5 MILLION in cash (as of 30 Sep 2020)

That should hold them for about 4 years at the current burn rate of about $50 million per year.

https://sec.report/Document/0001628280-20-016249/
👍️0
Fress Fress 4 years ago
Anxiety depression drug companies.
1.VTGN market cap $150 million 115 million in cash has Phase 3 & Phase 2's (Pandemic through U.S. FDA's Coronavirus Treatment Acceleration Program (CTAP)
2 $CMPS2.0 BILLIION early trials 180 million cash
3 $MMED 1.1 BILLION phase 2 raised 40 million in cash
4 $SAGE 3 Billion market cap bought out a few weeks ago for deperession anxiety pipeline


$CMPS
👍️0